keyword
https://read.qxmd.com/read/38622766/effects-of-sglt2-inhibitors-on-cause-specific-cardiovascular-death-in-patients-with-chronic-kidney-disease-a-meta-analysis-of-ckd-progression-trials
#1
JOURNAL ARTICLE
Robert A Fletcher, William G Herrington, Rajiv Agarwal, Kaitlin J Mayne, Clare Arnott, Meg J Jardine, Kenneth W Mahaffey, Vlado Perkovic, Natalie Staplin, David C Wheeler, Glenn M Chertow, Hiddo J L Heerspink, Brendon L Neuen
No abstract text is available yet for this article.
April 16, 2024: Clinical Journal of the American Society of Nephrology: CJASN
https://read.qxmd.com/read/38590597/ohca-in-bosnia-and-herzegovina-before-and-during-the-covid-19-pandemic
#2
JOURNAL ARTICLE
Armin Sljivo, Arian Abdulkhaliq, Ahmed Mulac, Vlado Lukic, Ivona Margeta, Marija Rako, Emira Kapisazovic
BACKGROUND: Out-of-hospital cardiac arrest (OHCA) refers to the cessation of mechanical cardiac activity outside healthcare facilities which requires prompt intervention and intensive resuscitative efforts. The COVID-19 pandemic has caused significant disruptions to OHCA systems-of-care, adversely affecting every component of the chain of survival. OBJECTIVE: The objective of this study was to examine the potential impacts of the COVID-19 pandemic on OHCA events, to draw comparisons between the period before and during the COVID-19 pandemic...
2024: Materia Socio-medica
https://read.qxmd.com/read/38583093/sodium-glucose-co-transporter-2-inhibitors-and-major-adverse-cardiovascular-outcomes-a-smart-c-collaborative-meta-analysis
#3
JOURNAL ARTICLE
Siddharth M Patel, Yu Mi Kang, KyungAh Im, Brendon L Neuen, Stefan D Anker, Deepak L Bhatt, Javed Butler, David Z I Cherney, Brian L Claggett, Robert A Fletcher, William G Herrington, Silvio E Inzucchi, Meg J Jardine, Kenneth W Mahaffey, Darren K McGuire, John J V McMurray, Bruce Neal, Milton Packer, Vlado Perkovic, Scott D Solomon, Natalie Staplin, Muthiah Vaduganathan, Christoph Wanner, David C Wheeler, Faiez Zannad, Yujie Zhao, Hiddo J L Heerspink, Marc S Sabatine, Stephen D Wiviott
BACKGROUND: Sodium glucose co-transporter 2 inhibitors (SGLT2i) consistently improve heart failure and kidney-related outcomes; however, effects on major adverse cardiovascular events (MACE) across different patient populations are less clear. METHODS: This was a collaborative trial-level meta-analysis from the SGLT2i meta-analysis cardio-renal trialists consortium, which includes all phase 3, placebo-controlled, outcomes trials of SGLT2i across three patient populations (diabetes at high risk for atherosclerotic cardiovascular disease [ASCVD], heart failure [HF], or chronic kidney disease [CKD])...
April 7, 2024: Circulation
https://read.qxmd.com/read/38564654/combination-treatment-with-verinurad-and-allopurinol-in-ckd-a-randomized-placebo-and-active-controlled-trial
#4
JOURNAL ARTICLE
Hiddo J L Heerspink, Austin G Stack, Robert Terkeltaub, Niels Jongs, Lesley A Inker, Magnus Bjursell, Noha Maklad, Shira Perl, Olof Eklund, Tord Rikte, C David Sjöström, Vlado Perkovic
No abstract text is available yet for this article.
February 20, 2024: Journal of the American Society of Nephrology: JASN
https://read.qxmd.com/read/38481511/barriers-to-care-new%C3%A2-medications-and-ckd
#5
EDITORIAL
Dana Kim, Vlado Perkovic, Sradha Kotwal
No abstract text is available yet for this article.
March 2024: KI Reports
https://read.qxmd.com/read/38383961/daprodustat-and-heart-failure-in-ckd
#6
JOURNAL ARTICLE
Jonathan W Cunningham, Brian L Claggett, Renato D Lopes, John J V McMurray, Vlado Perkovic, Kevin Carroll, Thomas Hiemstra, Kaivan Khavandi, Mary Ann Lukas, Prerna Ranganathan, Jennifer Shannon, Janet van Adelsberg, Ajay K Singh, Scott D Solomon
No abstract text is available yet for this article.
February 22, 2024: Journal of the American Society of Nephrology: JASN
https://read.qxmd.com/read/38379676/older-adults-perceptions-of-online-physical-exercise-management
#7
JOURNAL ARTICLE
Judita Peterlin, Vlado Dimovski, Simon Colnar, Bojan Blažica, Anamarija Kejžar
The study addresses the challenges of digitally transforming physical exercises for older adults (aged more than 55 years) to be performed in virtual environments (during the COVID-19 pandemic) as a long-term proactive strategic initiative in response to the global ageing society and technological development trend. A focus group with a sample of 24 older adults and three trainers were used as part of a 3-month physical exercise pilot conducted by the Jožef Stefan Institute to identify the skills and well-being gained and identify factors that influence success with online exercises for older adults on the individual and organisational levels...
2024: Frontiers in Public Health
https://read.qxmd.com/read/38344725/the-prevalence-of-ckd-in-australian-primary-care-analysis-of-a-national-general-practice%C3%A2-dataset
#8
JOURNAL ARTICLE
Min Jun, James Wick, Brendon L Neuen, Sradha Kotwal, Sunil V Badve, Mark Woodward, John Chalmers, David Peiris, Anthony Rodgers, Kellie Nallaiah, Meg J Jardine, Vlado Perkovic, Martin Gallagher, Paul E Ronksley
INTRODUCTION: The prevalence of chronic kidney disease (CKD) in Australia varies substantially across reports. Using a large, nationally representative general practice data source, we determined the contemporary prevalence and staging of CKD in the Australian primary care. METHODS: We performed a retrospective, community-based observational study of 2,720,529 adults with ≥1 visit to a general practice participating in the MedicineInsight program and ≥1 serum creatinine measurement (with or without a urine albumin-to-creatinine ratio [UACR] measurement) between 2011 and 2020...
February 2024: KI Reports
https://read.qxmd.com/read/38265126/treatment-of-residual-palatal-collapse-in-hypoglossal-nerve-stimulation-using-a-palatal-device
#9
Samuel Tschopp, Vlado Janjic, Urs Borner, Kurt Tschopp
Hypoglossal nerve stimulation (HNS) has increasingly become an alternative therapy for obstructive sleep apnea patients with CPAP intolerance. Stimulation of the hypoglossal nerve during sleep enhances airway patency and alleviates collapse. Suboptimal responses to HNS often stem from insufficient palatal coupling and residual velar collapse. Combining palatal devices, such as Velumount®, with HNS represents a simple and cost-effective strategy to treat residual palatal collapse. Patients desiring conservative treatment for residual palatal obstruction under HNS may consider this combined approach...
January 24, 2024: Laryngoscope
https://read.qxmd.com/read/38261535/valor-ckd-a-multicenter-randomized-double-blind-placebo-controlled-trial-evaluating-veverimer-in-slowing-progression-of-ckd-in-patients-with-metabolic-acidosis
#10
RANDOMIZED CONTROLLED TRIAL
Navdeep Tangri, Vandana S Mathur, David A Bushinsky, Gerrit Klaerner, Elizabeth Li, Dawn Parsell, Yuri Stasiv, Michael Walker, Donald E Wesson, David C Wheeler, Vlado Perkovic, Lesley A Inker
SIGNIFICANCE STATEMENT: Metabolic acidosis is a common complication of CKD and is associated with more rapid decline of kidney function, but well-powered controlled randomized trials testing the effect of treating metabolic acidosis on slowing CKD progression have not been conducted. The VALOR-CKD study randomized 1480 individuals with CKD and metabolic acidosis, across 320 sites to placebo or veverimer (a novel hydrochloric acid binder). The findings did not demonstrate the efficacy of veverimer in slowing CKD progression, but the difference in serum bicarbonate between placebo and drug arms was only approximately 1 mEq/L...
March 1, 2024: Journal of the American Society of Nephrology: JASN
https://read.qxmd.com/read/38252809/impact-of-canagliflozin-on-kidney-and-cardiovascular-outcomes-by-type-2-diabetes-duration-a-pooled-analysis-of-the-canvas-program-and-credence-trials
#11
JOURNAL ARTICLE
Sheldon W Tobe, Thomas A Mavrakanas, Harpreet S Bajaj, Adeera Levin, Navdeep Tangri, April Slee, Brendon L Neuen, Vlado Perkovic, Kenneth W Mahaffey, Wally Rapattoni, Fernando G Ang
OBJECTIVE: The study was undertaken because it was unknown whether the duration of type 2 diabetes modifies the effects of sodium-glucose cotransporter 2 inhibitor canagliflozin on cardiovascular (CV) and kidney outcomes. RESEARCH DESIGN AND METHODS: This post hoc analysis of the Canagliflozin Cardiovascular Assessment Study (CANVAS) Program (N = 10,142) and Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy (CREDENCE) trial (N = 4,401) evaluated hazard ratios and 95% CIs using Cox proportional hazards for the effects of canagliflozin on CV and kidney outcomes, including progression and regression of albuminuria over 5-year intervals of disease duration...
March 1, 2024: Diabetes Care
https://read.qxmd.com/read/38247978/perceptions-of-patients-caregivers-and-healthcare-professionals-toward-telemedicine-use-for-cognitive-and-movement-disorders-in-the-aegean-islands-greece-a-pilot-study-of-the-si4care-european-project
#12
JOURNAL ARTICLE
Efthalia Angelopoulou, Dionysia Kontaxopoulou, Stella Fragkiadaki, Evangelia Stanitsa, Dimosthenis Pavlou, John Papatriantafyllou, Christos Koros, Vlado Dimovski, Darja Šemrov, Sokratis G Papageorgiou
BACKGROUND: Patients with neurodegenerative diseases who live in remote areas often have limited access to specialized healthcare, and telemedicine represents a useful solution. The aim of this study was to investigate the perceptions toward the use of a specialized-tertiary telemedicine service of patients with cognitive and movement disorders, caregivers, and local healthcare professionals (HPs) in the Aegean Islands. METHODS: Data were derived from the "Specialized Outpatient Clinic of Memory, Dementia and Parkinson's disease through the National Telemedicine Network", March 2021-March 2023...
December 26, 2023: Geriatrics
https://read.qxmd.com/read/38243070/author-correction-first-basin-scale-spatial-temporal-characterization-of-underwater-sound-in-the-mediterranean-sea
#13
Marta Picciulin, Antonio Petrizzo, Fantina Madricardo, Andrea Barbanti, Mauro Bastianini, Ilaria Biagiotti, Sofia Bosi, Michele Centurelli, Antonio Codarin, Ilaria Costantini, Vlado Dadić, Raffaela Falkner, Thomas Folegot, Daphnie Galvez, Iole Leonori, Stefano Menegon, Hrvoje Mihanović, Stipe Muslim, Alice Pari, Sauro Pari, Grgur Pleslić, Marko Radulović, Nikolina Rako-Gospić, Davide Sabbatini, Jaroslaw Tegowski, Predrag Vukadin, Michol Ghezzo
No abstract text is available yet for this article.
January 19, 2024: Scientific Reports
https://read.qxmd.com/read/38240199/primary-and-secondary-cardiovascular-and-kidney-prevention-with-canagliflozin-insights-from-the-canvas-program-and-credence-trial
#14
JOURNAL ARTICLE
Abhinav Sharma, Amir Razaghizad, Abdulaziz Joury, Adeera Levin, Harpreet S Bajaj, G B John Mancini, Norman C Wong, April Slee, Fernando G Ang, Wally Rapattoni, Brendon L Neuen, Clare Arnott, Vlado Perkovic, Kenneth W Mahaffey
BACKGROUND: This study evaluated the effects of canagliflozin in patients with type 2 diabetes with and without prevalent cardiovascular disease (secondary and primary prevention). METHODS AND RESULTS: This was a pooled participant-level analysis of the CANVAS (Canagliflozin Cardiovascular Assessment Study) Program and CREDENCE (Canagliflozin and Renal Events in Diabetes With Established Nephropathy Clinical Evaluation) trial. The CANVAS Program included participants with type 2 diabetes at elevated cardiovascular risk, whereas the CREDENCE trial included participants with type 2 diabetes and albuminuric chronic kidney disease...
February 6, 2024: Journal of the American Heart Association
https://read.qxmd.com/read/38192747/estimating-the-population-level-impacts-of-improved-uptake-of-sglt2-inhibitors-in-patients-with-chronic-kidney-disease-a-cross-sectional-observational-study-using-routinely-collected-australian-primary-care-data
#15
JOURNAL ARTICLE
Brendon L Neuen, Min Jun, James Wick, Sradha Kotwal, Sunil V Badve, Meg J Jardine, Martin Gallagher, John Chalmers, Kellie Nallaiah, Vlado Perkovic, David Peiris, Anthony Rodgers, Mark Woodward, Paul E Ronksley
BACKGROUND: Sodium glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of kidney failure and death in patients with chronic kidney disease (CKD) but are underused. We evaluated the number of patients with CKD in Australia that would be eligible for treatment and estimated the number of cardiorenal and kidney failure events that could be averted with improved uptake of SGLT2 inhibitors. METHODS: This cross-sectional observational study leveraged nationally representative primary care data from 392 Australian general practices (MedicineInsight) between 1 January 2020 and 31 December 2021...
February 2024: The Lancet Regional Health. Western Pacific
https://read.qxmd.com/read/38179591/the-point-of-care-peritoneal-dialysis-system-early-evaluation-study-poc-pdee-a-pilot-proof-of-principal-study-of-the-ellen-medical-devices-point-of-care-affordable-peritoneal-dialysis-system
#16
JOURNAL ARTICLE
Benjamin Talbot, Simon Davies, Jenny Burman, Angus Ritchie, Paul Snelling, Sue Lynch, Youn Park, Brian Jones, Vincent Garvey, Allison Jaure, Meg Jardine, Vlado Perkovic, Martin Gallagher, Arthur Brandwood, Navneet Kaur, John Knight
The global unmet need for kidney replacement therapy means that millions of people die every year as they cannot afford treatment. Peritoneal dialysis (PD) offers comparable survival to haemodialysis and is often more affordable, but one barrier to increasing access is that conventional manufacturing and distribution of PD fluid is costly. Here we report the results from a pilot proof-of-principal study demonstrating for the first time that the Ellen Medical Devices Point-of-Care system can be used by patients to produce sterile PD fluid at the point-of-care...
January 5, 2024: Peritoneal Dialysis International
https://read.qxmd.com/read/38170502/hypoglycemia-and-cardiovascular-outcomes-in-the-carmelina-and-carolina-trials-of-linagliptin-a-secondary-analysis-of-randomized-clinical-trials
#17
JOURNAL ARTICLE
Nikolaus Marx, Ahmed A Kolkailah, Julio Rosenstock, Odd Erik Johansen, Mark E Cooper, John H Alexander, Robert D Toto, Christoph Wanner, Mark A Espeland, Michaela Mattheus, Sven Schnaidt, Vlado Perkovic, Nicholas D Gollop, Darren K McGuire
IMPORTANCE: Previous studies have reported an association between hypoglycemia and cardiovascular (CV) events in people with type 2 diabetes (T2D), but it is unclear if this association is causal or identifies a high-risk patient phenotype. OBJECTIVE: To evaluate the associations between hypoglycemia and CV outcomes. DESIGN, SETTING, AND PARTICIPANTS: This secondary analysis was a post hoc assessment of the multinational, double-blind CARMELINA (Cardiovascular and Renal Microvascular Outcome Study With Linagliptin; 2013-2016) and CAROLINA (Cardiovascular Outcome Trial of Linagliptin vs Glimepiride in Type 2 Diabetes; 2010-2018) randomized clinical trials of the antihyperglycemic drug, linagliptin, a dipeptidyl peptidase 4 inhibitor...
January 3, 2024: JAMA Cardiology
https://read.qxmd.com/read/38129457/first-basin-scale-spatial-temporal-characterization-of-underwater-sound-in-the-mediterranean-sea
#18
JOURNAL ARTICLE
Picciulin Marta, Petrizzo Antonio, Madricardo Fantina, Barbanti Andrea, Bastianini Mauro, Biagiotti Ilaria, Bosi Sofia, Centurelli Michele, Codarin Antonio, Costantini Ilaria, Dadić Vlado, Falkner Raffaela, Folegot Thomas, Galvez Daphnie, Leonori Iole, Menegon Stefano, Mihanović Hrvoje, Muslim Stipe, Pari Alice, Pari Sauro, Pleslić Grgur, Radulović Marko, Rako-Gospić Nikolina, Sabbatini Davide, Tegowski Jaroslaw, Vukadin Predrag, Ghezzo Michol
Anthropogenic underwater noise is an emergent pollutant. Despite several worldwide monitoring programs, only few data are available for the Mediterranean Sea, one of the global biodiversity hotspots. The results of the first continuous acoustic programme run at a transnational basin scale in the Mediterranean Sea are here presented. Recordings were done from March 2020 to June 2021, including the COVID-19 lockdown, at nine stations in the Northern Adriatic Sea. Spatial-temporal variations of the underwater sound are described, having one third octave band sound pressure levels (SPLs) from 10 Hz to 20 kHz as metrics...
December 20, 2023: Scientific Reports
https://read.qxmd.com/read/38109442/unveiling-the-neuropathology-tumour-landscape-10-year-statistical-analysis-with-global-comparison-single-centre-experience
#19
JOURNAL ARTICLE
Panche Zdravkovski, Boro Ilievski, Vladimir Rendevski, Aleksandar Chaparoski, Venko Filipce, Aleksandar Zupanoski, Aleksandra Dimovska Gavrilovska, Blagoj Shuntov, Vlado Stolevski, Igor Stojkovski, Menka Lazareska, Ana Mihajlovska Rendevska, Gordana Petrushevska
Introduction : Central nervous system (CNS) tumours represent a significant public health issue worldwide, and their incidence and distribution vary across different populations. Although studies on CNS tumours have been conducted in various countries, there is a lack of information regarding their patterns in Macedonia. Therefore, this study is aimed at investigating the distribution, histopathological types and subtypes and demographic features of CNS tumours in our country. Materials and Methods : A cross sectional study was conducted using the electronic database of the Institute of Pathology - Medical Faculty, University "Ss...
December 1, 2023: Prilozi (Makedonska Akademija Na Naukite i Umetnostite. Oddelenie za Medicinski Nauki)
https://read.qxmd.com/read/38088558/effect-of-ziltivekimab-on-determinants-of-hemoglobin-in-patients-with-ckd-stage-3-5-an-analysis-of-a-randomized-trial-rescue
#20
RANDOMIZED CONTROLLED TRIAL
Pablo E Pergola, Michael Davidson, Camilla Jensen, Amir A Mohseni Zonoozi, Dominic S Raj, Philip Andreas Schytz, Katherine R Tuttle, Vlado Perkovic
SIGNIFICANCE STATEMENT: Systemic inflammation in CKD can lead to anemia. Ziltivekimab, a fully human monoclonal antibody targeting the IL-6 ligand, has been shown to reduce systemic inflammation in patients with CKD. It has also been shown to increase serum albumin in patients on hemodialysis with inflammation and hyporesponsiveness to treatment with erythropoiesis-stimulating agents. This exploratory analysis of the RESCUE clinical trial found that among patients with CKD stage 3-5 and systemic inflammation, ziltivekimab treatment significantly increased hemoglobin (Hb) levels after 12 weeks compared with placebo...
January 1, 2024: Journal of the American Society of Nephrology: JASN
keyword
keyword
82729
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.